Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e019980e0d3964666d42b84f16f7fe2a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate |
2007-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc14ccb16c91abd70b58a1a7e9f34a15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a847c1b9ddaa81172c6aaa853c4e973e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccfe8bec3e16fae2169d9b8706474f42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa469c582e8c6171cf9de2e2926ef6c |
publicationDate |
2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NO-20075046-L |
titleOfInvention |
Gastroresistant pharmaceutical formulations containing rifaximin |
abstract |
The object of the invention is to provide pharmaceutical formulations containing rifaximin in the form of microgranules made gastroresistant with an insoluble polymer at pH values between 1.5 and 4.0 and soluble at pH values between 5.0 and 7.5, their preparation and their use in the manufacture of medicinal preparations useful in the treatment of inflammatory bowel disease (IBD) and mainly Crohn's disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20083988-L http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-345200-B1 |
priorityDate |
2005-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |